Skip to main content
Equibles
DOC logo

DOC · Healthpeak Properties, Inc. · Metrics

Track DOC — free

Use DOC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DOC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.17 +0.61 (+3.12%) At close · Nov 4 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$13.91B
Shares
689.54M
Volume · Nov 4 8.7M Avg daily vol (3M) 5.53M

DOC metrics

94 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.17
Market cap
$13.91B

Price action

20 metrics
Price change (1W)
+2.8%
Price change (30D)
+3.8%
Price change (3M)
-9.5%
Price change (6M)
+18.5%
Price change (YTD)
+21.6%
Price change (1Y)
+10.6%
Trailing year
Price change (5Y)
-44.0%
52-week high
$22.82
52-week low
$15.78
Change from 52-week high
-14.3%
Change from 52-week low
+24.0%
Annualized volatility
29.4%
Annualized volatility (3M)
23.4%
Beta
0.4
RSI (14D)
54.0
Price vs SMA 50
-1.3%
Price vs SMA 200
+2.1%
Avg volume (3M)
5.52M
Relative volume
1.8
Average dollar volume
$110.48M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
689.54M

Valuation

14 metrics
P / FFO
10.8×
Company-stated · FY2025 · reciprocal yield 9.3%
P / AFFO
11.6×
Company-stated · FY2025 · reciprocal yield 8.6%
P / E (TTM)
36.2
Trailing earnings · reciprocal yield 2.8%
PEG ratio
—
EV / revenue
7.3×
reciprocal yield 13.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.4×
reciprocal yield 22.7%
P / book
1.7
reciprocal yield 58.3%
FCF yield
—
TTM · current market cap
Buyback yield
0.8%
P / FCF
—
P / operating cash flow
10.6
reciprocal yield 9.4%
Earnings yield
2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
61.8×
reciprocal yield 1.6%
P / E historical average (5Y)
49.4×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
8.2×
reciprocal yield 12.2%
EV / revenue historical average (5Y)
9.1×
reciprocal yield 11.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
6.3%
Trailing 12 months
Payout ratio
223.6%
Shareholder yield
7.0%
Dividend / share (TTM)
$1.22
Dividend growth YoY
+20.1%
Dividend growth streak
1
Last ex-dividend
2026-10-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-03

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
12.3%
Gross profit (TTM)
$1.68B
Operating profit (TTM)
—
Net income (TTM)
$377.68M
Trailing 12 months
Diluted EPS (TTM)
$0.54
FCF margin
—
Effective tax rate
1.5%

Per share

13 metrics
FFO per diluted share
$1.81
Company-stated · FY2025
AFFO per diluted share
$1.69
Company-stated · FY2025
Revenue per diluted share (TTM)
$4.43
Gross profit per diluted share (TTM)
$2.41
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.54
Operating cash flow per diluted share (TTM)
$1.84
Free cash flow per diluted share (TTM)
$1.61
Capital expenditures per diluted share (TTM)
$0.98
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.03
Book value per share
$10.79

Growth

11 metrics
Revenue growth YoY
+16.3%
Year over year
Net income growth YoY
-70.7%
Revenue (TTM)
$3.06B
Trailing 12 months
EPS growth YoY
-72.2%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.0%
Revenue CAGR (5Y)
+11.4%
EPS CAGR (3Y)
-52.3%
EPS CAGR (5Y)
-33.5%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
4.8%
Return on assets
1.7%
Debt / equity
1.2
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$8.87B
Latest balance sheet
Cash & equivalents
$514.31M
Total assets
$22.41B
Total debt
$9.38B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.27B
Capital expenditures (TTM)
$458.90M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$18.17M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

9 metrics
13F filers
772
13F filer change QoQ
+3
Institutional ownership
96.1%
Conviction holders (share of 13F filers)
0.5%
Crowding (high-turnover and private-fund holders)
11.7%
Private-fund adviser ownership
10.7%
Active holders' share change QoQ
-6.4%
Holder tenure
16.7
Price vs estimated holder cost
+15.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
30.3%

Short interest

3 metrics
Short interest
3.2%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 765880 CUSIP 42250P103 13F (30d) 354 filings 326 filers Visit website Investor relations